Navigation Links
E-cigarettes far less harmful than cigarettes, says Lancet researcher at INFORMS Conference
Date:6/16/2014

A London School of Economics researcher examining the public and private dangers of drugs argues against demonizing e-cigarettes in a presentation being given at a conference of the Institute for Operations Research and the Management Sciences (INFORMS). He also calls on public officials to recognize that alcohol causes greater harm than other recreational drugs and more public attention should be paid to controlling its harmful effects.

Lawrence D. Phillips, an emeritus professor at the London School of Economics, will present his research group's findings about the relative risks of different drugs at Advances in Decision Analysis, a conference sponsored by the INFORMS Decision Analysis Society (DAS). The conference takes place June 16-18 at Georgetown University in Washington, DC.

A recent workshop facilitated by Prof. Phillips led a group of researchers to write a letter to the World Health Organization advocating against the classification of e-cigarettes as tobacco. They argued that e-cigarettes should be classified as a device for fighting nicotine addiction. . " It is well known that 'people smoke for the nicotine, but die from the smoke'," he says.

In his upcoming presentation, Prof. Philips draws on a study about drugs in the United Kingdom he co-authored in 2010 that was published in The Lancet. "Drug Harms in the UK: A Multi-Criteria Analysis" has lessons that can be applied in the U.S. and across the world, he says.

The 2010 results are based on an expert panel that was called upon to use participants' judgment to assess the relative harm of 20 different drugs. Because the drugs are illegal and data is extremely difficult to obtain, the participants relied on their collective knowledge and experience to score the drugs and a decision analysis model to aggregate the judgments.

Similar results were obtained in 2013 among a group assessing drug risk in Europe. A .993 correlation between the two panels, which contained different sets of experts, is considered extremely high.

A 2013 expert panel about the relative harm of 12 nicotine products named cigarettes the most harmful but ranked e-cigarettes near the bottom, in ninth place. Prof. Phillips explores its results in his presentation at Georgetown University.

The various panels used decision analysis to determine psychological, physical and social harm to users and to those around them. Members of the United Kingdom's Independent Scientific Committee on Drugs scored 20 drugs on 16 criteria.

Decision analysis of the UK panel ratings showed that heroin, crack cocaine, and methamphetamine were the most harmful drugs to individuals (scoring 34, 37, and 32, respectively). Alcohol, heroin, and crack cocaine were the most harmful to others (46, 21, and 17).

Overall, alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (54) in second and third places. Similar results were found when analyzing the continental Europe panel.

Several experts from the drug harm workshop, including The Lancet study's co-author David Nutt, the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Department of Neuropsychopharmacology and Molecular Imaging at Imperial College London, have called on British and international health organizations like WHO to adjust their guidelines about dangerous drugs based on the findings.

In the 2010 paper, they write, "the present drug classification systems have little relation to the evidence of harm. They also accord with the conclusions of previous expert reports that aggressively targeting alcohol harms is a valid and necessary public health strategy."

Prof. Phillips notes the important role of judgment in quantitative models, particularly when there is limited data available, as was the case for these panels. The 20 drugs rated in the studies were alcohol, amphetamines, anabolic steroids, benzodiazepines, buprenorphine, butane, cannabis, cocaine, crack, Ecstasy, GHB, heroin, ketamine, khat, LST, mephedrone, methadone, methamphetamine, mushrooms, and tobacco.

The combined research shows the important role for judgment in quantitative models, particularly when there is very little data available, as in research about illegal drugs. The decision science techniques provided new tools to reevaluate common perceptions and laws governing hazardous drugs.
'/>"/>

Contact: Barry List
barry.list@informs.org
443-794-5182
Institute for Operations Research and the Management Sciences
Source:Eurekalert

Related medicine news :

1. E-cigarettes: More than just hot air
2. Cool factor separates e-cigarettes from nicotine inhalers
3. E-cigarettes: Not a healthy alternative to smoking
4. Fewer smokers believe e-cigarettes are a safer alternative to cigarettes
5. E-cigarettes and mental health
6. Young parents who use e-cigarettes believe devices are safer for those around them
7. E-cigarettes: Gateway to nicotine addiction for US teens, says UCSF study
8. 44 percent of adults worry e-cigarettes will encourage kids to start smoking tobacco
9. First trial to compare e-cigarettes with nicotine patches
10. UIC researchers to study how young adults use e-cigarettes, snus
11. Experts warn that e-cigarettes can damage the lungs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... , ... February 19, 2020 , ... ... Advanced Periodontics and Dental Implant Center of Connecticut, celebrate 30 years of serving ... with the same low fees that they charged in 1989, only thirty dollars. ...
(Date:2/19/2020)... ... 19, 2020 , ... MedTech IGNITE Expands Steering Committee, Faculty ... in 2020 Cohort , The Massachusetts Medical Device Industry Council ( MassMEDIC ) ... from startup founders and CEOs to participate in the 2020 IGNITE Cohort. ...
(Date:2/19/2020)... ... February 19, 2020 , ... Nvision Biomedical Technologies , ... portfolio for lower extremities at the American College of Foot and Ankle Surgeons ... Trigon® Ti Stand-Alone Osteotomy Wedge Fixation System will lead Nvision's innovative showcase. The ...
(Date:2/16/2020)... ... February 16, 2020 , ... Accumen Inc., the leader in ... and The Joint Commission to provide a complimentary series of Patient Blood Management ... and transfusion safety officers) within U.S. hospitals. , “Accumen’s mission is ...
(Date:2/15/2020)... ... February 14, 2020 , ... Sister companies, Special Learning ... “BIG MONEY IN ABA”. The series explores the challenges, risks, and opportunities of ... the series on March 25, 2020 at: https://bit.ly/2OU6lxg , Since 2010, ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... and FT. LAUDERDALE, Fla. (PRWEB) , ... February 14, 2020 , ... ... area, has joined the esteemed Haute Beauty Network. , The Haute Beauty Network, well ... Dr. Ray Lopez as a foot and ankle and our newest addition to the ...
(Date:2/15/2020)... ... , ... The creators of Dullo Plus - a premium cotton pillow ... to announce the launch of a Kickstarter campaign for 35 days starting, February 11, ... the last four years. Dullo Plus is their most advanced pillow to date , ...
(Date:2/14/2020)... , ... February 14, 2020 , ... ... medical services (EMS), fire departments and hospitals, today announced Dr. Daniel Kraft – ... of Exponential Medicine – will deliver one of three keynote presentations at ...
Breaking Medicine Technology: